Endocrine Society Leads Efforts to Lower Cost of Prescription Drugs

The Endocrine Society continues to lead advocacy efforts focused on lowering the cost of diabetes medication. The Society has weighed in on recent congressional and administration activity regarding legislation and regulations aimed at lowering the price of prescription drugs.    In May, the House Energy & Commerce Health subcommittee conducted a hearing on legislation to lower the cost of prescription drugs. The Endocrine Society submitted a statement to the subcommittee calling on Congress to […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:

Share this article